16.12.2012 Views

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Publication After 18 month<br />

The following Patent application have been published under Section 11A <strong>of</strong> the <strong>Patents</strong><br />

(Amendment) Act, <strong>2005</strong><br />

(21) Application No.:<br />

(54) Title <strong>of</strong> the invention:<br />

509/MUMNP/2004<br />

PCT/ ep00/03717<br />

Date: 19/04/2000<br />

(51) International classification: C 12 N 15/13 (71)<br />

(30) Priority Data :<br />

(31) Document No.: 99303117.8<br />

(32) Date : 22/04/1999<br />

(33) Name <strong>of</strong> convention country : EUROPE<br />

(66) Filed U/s. 5(2) : NO<br />

(61) Patent <strong>of</strong> addition to application No.: NIL<br />

(62) Filed on : N.A.<br />

(63) Divisional to<br />

Application No.: IN/ PCT/2001/01267/MUM<br />

(64) Filed on : N.A.<br />

(57) Abstract:<br />

A (22) Date <strong>of</strong> filing <strong>of</strong><br />

Application:<br />

15/09/2004<br />

INHIBITION OF VIRAL INFECTION USING<br />

MONOVALENT ANTIGEN- BINDING PROTEINS.<br />

(72)<br />

Name <strong>of</strong> the Applicant:<br />

HINDUSTAN LEVER LIMITED.<br />

Address <strong>of</strong> the Applicant:<br />

HINDUSTAN LEVER HOUSE,<br />

165/166,BACKBAY<br />

RECLAMATION,<br />

MUMBAI-400020,<br />

MAHARASHTRA, INDIA.<br />

Name <strong>of</strong> the Inventors<br />

1. BEZEMER SANDRA<br />

2. FRENKEN LEON<br />

3. DE HARDJOGEN<br />

4. LEDEBOER ADRIANUS<br />

5. VERRIPS CORNELIS<br />

A method <strong>of</strong> inhibiting viral infection using a monovalent antigen binding protein comprising a<br />

single domain binding unit capable <strong>of</strong> binding to a virus is described. Preferably the protein is a<br />

heavy chain variable domain derive from an immunoglobulin naturally devoid <strong>of</strong> light chains.<br />

Food pharmaceutical <strong>and</strong> cosmetic products comprising such proteins are also described together<br />

with a method for selecting inhibiting proteins from a large population <strong>of</strong> mainly containing noninhibiting,<br />

but infectious agent binding fragments.<br />

Figure: NIL<br />

The Patent Office Journal <strong>24</strong>.<strong>06</strong>.<strong>2005</strong> 17945

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!